| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |